Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
The field is reaching a point where sleep health will become a top priority for public health as a result of the great strides made in the field over the past year, as well as the effects of the COVID-19 pandemic and lingering care challenges.
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer
2.
Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer
3.
Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again
4.
New study elucidates obesity's role in fueling breast cancer progression
5.
EMA OKs Two Treatments for Small Cell Lung Cancer
1.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
2.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
3.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
4.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
5.
Unlocking The Causes And Risk Factors Of Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XVI
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge